Davidson Michael H.

Chief Executive Officer at NAMS

Sold, on record
$25.3M
Dollars the filings state
Form 4 sales
4
Latest Mar 2, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • NAMSNewAmsterdam Pharma Co N.V.Chief Executive Officer

Sales by reason

2
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale NAMSNo plan
    Mar 26, 2025 2025

    Sold 12,258 shares

    Davidson Michael H., Chief Executive Officer

    No 10b5-1 planSold 3% of holdings390,441 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale NAMSRoutine
    Jan 7, 2026 +287 days

    Sold 11,582 shares

    Davidson Michael H., Chief Executive Officer

    10b5-1 planSold 3% of holdings378,859 shares leftFiling

  3. 3 Form 4 sale NAMSRoutine
    Feb 26, 2026 +50 days

    Sold 306,293 shares at $34.53 ($10.6M)

    Davidson Michael H., Chief Executive Officer

    10b5-1 planSold 63.8% of holdings ($16.6M position)174,144 shares leftFiling

  4. 4 Form 4 sale NAMSUnusual
    Mar 2, 2026 +4 days

    Sold 443,707 shares at $33.25 ($14.8M)

    Davidson Michael H., Chief Executive Officer

    No 10b5-1 planSold 71.8% of holdings ($20.5M position)174,144 shares left36.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Davidson Michael H.
Source
Mar 2, 2026Mar 2, 2026NAMSChief Executive OfficerForm 4 sale443,707$14.8M71.8%UnusualSEC
Feb 26, 2026Feb 26, 2026NAMSChief Executive OfficerForm 4 sale306,293$10.6M63.8%RoutineSEC
Jan 7, 2026Jan 9, 2026NAMSChief Executive OfficerForm 4 sale11,5823.0%RoutineSEC
Mar 26, 2025Mar 28, 2025NAMSChief Executive OfficerForm 4 sale12,2583.0%No planSEC